ASX:COH Cochlear (COH) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Cochlear Stock (ASX:COH) 30 days 90 days 365 days Advanced Chart Get Cochlear alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume201,277 shsAverage VolumeN/AMarket CapitalizationA$19.88 billionP/E Ratio55.90Dividend Yield1.35%Price TargetN/AConsensus RatingN/A Company Overview Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. The company was founded in 1981 and is headquartered in Sydney, Australia. Read More Receive COH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cochlear and its competitors with MarketBeat's FREE daily newsletter. Email Address COH Stock News HeadlinesAssistive tech targets market growth while improving livesAugust 6 at 7:01 PM | msn.comHealth Check: Aussie biotechs are navigating a US regulatory minefieldJuly 22, 2025 | msn.comThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.August 8 at 2:00 AM | Brownstone Research (Ad)What are Cochlear shares worth according to Macquarie?July 16, 2025 | msn.comHow to start your ASX share portfolio with just $1,000July 15, 2025 | msn.comUp 250% in a year, how much higher can this ASX healthcare share climb?July 2, 2025 | msn.comCochlear Ltd. (COH) Stock Price Today - WSJJune 30, 2025 | wsj.comCOH | Cochlear Ltd. Annual Income Statement | MarketWatchJune 24, 2025 | marketwatch.comSee More Headlines COH Stock Analysis - Frequently Asked Questions How were Cochlear's earnings last quarter? Cochlear Limited (ASX:COH) released its earnings results on Tuesday, February, 19th. The company reported $2.15 earnings per share for the quarter, missing analysts' consensus estimates of $2.19 by $0.04. Cochlear had a trailing twelve-month return on equity of 19.70% and a net margin of 15.80%. What other stocks do shareholders of Cochlear own? Based on aggregate information from My MarketBeat watchlists, some other companies that Cochlear investors own include CSL (CSL), ResMed (RMD), NIB (NHF), Accent Group (AX1), Corporate Travel Management (CTD), Mineral Resources (MIN) and Technology One (TNE). Company Calendar Last Earnings2/19/2019Today8/08/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolASX:COH CIKN/A Webwww.cochlear.com Phone+61-2-94286555FaxN/AEmployees4,996Year FoundedN/AProfitability EPS (Trailing Twelve Months)A$5.43 Trailing P/E Ratio55.90 Forward P/E RatioN/A P/E Growth3.87Net IncomeA$356.80 million Net Margins15.80% Pretax MarginN/A Return on Equity19.70% Return on Assets11.99% Debt Debt-to-Equity Ratio13.24 Current Ratio2.30 Quick Ratio1.93 Sales & Book Value Annual SalesA$2.24 billion Price / Sales0.00 Cash FlowN/A Price / Cash Flow123.45 Book ValueA$28.10 per share Price / BookN/AMiscellaneous Outstanding Shares65,500,000Free FloatN/AMarket CapA$19.88 billion OptionableNot Optionable Beta0.47 The 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report This page (ASX:COH) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cochlear Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Cochlear With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.